A simplified and sensitive LC-APCI-MS/MS method for the quantification of propofol: Application to a bioequivalence study in healthy Chinese subjects
Ling Tang,KeLi Wang,Chun Peng,XuanWei Li,Le Li,Yan Wang,Li Ding
DOI: https://doi.org/10.5414/CP203821
2020-01-01
International Journal of Clinical Pharmacology and Therapeutics
Abstract:Objectives: Propofol has become the preferred anesthetic in recent years due to its desirable pharmacologic properties. However, propofol possesses a very narrow therapeutic window between the favorable clinical effect and potentially lethal toxicity, therefore, a rapid, simplified, and sensitive liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry (LC-APCI-MS/MS) method is presented in this study for the quantification of propofol in human plasma using the isotope-labeled internal standard (IS) of propofol-d17, and then applied in a bioequivalence study. Materials and methods: Sample preparation was accomplished through simple one-step precipitation of plasma protein with acetonitrile. Chromatographic separation was acquired on an ACE Excel 3 Super C-18 column (2.1 x 50 mm, 3 mu m) using gradient elution at a flow rate of 0.5 mL/min. The MS detection was achieved in the negative ion APCI by multiple reaction monitoring (MRM) mode using the transitions of m/z 177.2 -> 161.0 for propofol and m/z 194.2 -> 174.2 for IS, respectively. 30 healthy Chinese subjects were enrolled in the open-label, randomized, two-period, two-sequence, cross-over bioequivalence study after single-dose intravenous administration of propofol medium-chain triglyceride and long-chain triglyceride (MCT/LCT). Results: The current method was precise and accurate at a linearity range of 4.00 - 1,000 ng/mL without severe interference from the plasma matrix. The inter-and intra-batch precision (2.3 to 15.8%) and accuracy (-4.4 to 3.0%), IS-normalized matrix effect (coefficient of variation <= 4.6%). extraction recovery (107.1 - 117.1%), stability (coefficient of variation <= 8.0%), and dilution integrity were all within the acceptable range. The 90% confidence intervals (CIs) of the ratios of the geometric means (test/reference) were 86.44 - 104.88% for C-max, 96.30 - 104.52% for AUC (0-t), and 96.56 - 105.05% for AUC(0-infinity), which were all within the predefined bioequivalence range of 80 - 125%. Besides, both propofol MCT/LCT preparations were well tolerated in healthy Chinese subjects, and there were no serious adverse events during the study. Conclusion: The method is more simplified and sensitive than the previously reported modes of propofol detection. The two propofol MCT/LCT preparations were considered to be bioequivalent. What is known about this subject - Propofol possesses a very narrow therapeutic window between the favorable clinical effect and potentially lethal toxicity: therefore, a rapid, sensitive, and selective method is required for the determination of propofol. - Various techniques have been reported for the detection of propofol in biological samples. However, most of these methods need cumbersome sample pretreatment processes, such as liquid-liquid extraction, solid-phase extraction, and derivatization, which arc not suitable for the high-throughput analysis of propofol. What this study adds - A novel method that combines sample pretreatment by one-step protein precipitation with LC-APCI-MS/MS analysis for the detection of propofol plasma concentration in healthy Chinese subjects was established and the validated method was applied to a bioequivalence study for the first time. - The fast sample extraction method and a short single run time of 4 minutes make it an attractive procedure in high-throughput analysis of propofol. It also provided the feasibility to quantify plasma concentrations as low as 4.00 ng/mL (LLOQ) for propofol. The method proposed in this study was not only simpler and faster but also more specific and sensitive than other published methods. - Pharmacokinetic parameters of propofol in healthy Chinese subjects were reported for the first time.